Centene Corporation ($CNC) Stock Forecast: Up 5.2% Today

What is Centene Corporation?

Centene (CNC) is a leading multi-national healthcare enterprise that provides programs and services to government-sponsored healthcare programs, focusing on under-insured and uninsured individuals. The company operates through two segments: Managed Care and Specialty Services.

Why is Centene Corporation going up?

CNC stock is up 5.2% on Apr 2, 2026 13:51

• CNC experienced a strong bullish movement today.
• The significant increase in stakes by HF Advisory Group LLC and Rockland Trust Co. in Elevance Health (ELV) could have positively impacted CNC's stock price, as ELV's strong financial performance and raised dividend likely boosted investor confidence in the healthcare sector.
• Leerink's report on UnitedHealth Group (UNH) facing substantial RADV audit exposure might have indirectly benefited CNC, as investors may have shifted their focus towards other healthcare companies with potentially lower audit risks.
• Overall, the positive sentiment surrounding healthcare stocks, driven by strong financial results and strategic investments, likely contributed to CNC's bullish market movement today.

CNC Price Chart

CNC Technical Analysis

CNC News

HF Advisory Group LLC Increases Stock Position in Elevance Health, Inc. $ELV

HF Advisory Group LLC significantly increased its stake in Elevance Health (NYSE: ELV) by 1,797% in Q4, acquiring an additional 144,655 shares to hold a total of 152,705 shares valued at approximately $53.53 million, making it their 7th largest holding. This comes as Elevance Health exceeded Q4 EPS estimates with strong revenue growth, raised its quarterly dividend, and maintains a "Moderate Buy" analyst rating. The company also reported solid financial metrics including a market cap of $65.68 billion and a P/E ratio of 11.90.

https://www.marketbeat.com/instant-alerts/filing-hf-advisory-group-llc-increases-stock-position-in-elevance-health-inc-elv-2026-04-02/

Cigna posts Q1 results by 6:30 a.m. ET, holds investor call April 30

The Cigna Group (NYSE: CI) announced it will release its first quarter 2026 financial results on April 30, 2026, by 6:30 a.m. ET. Management will host a conference call to discuss these results at 8:30 a.m. ET, with a live webcast and replay available. This announcement continues the company's established practice of pre-announcing earnings logistics, with historical data showing an average -5.52% stock move following previous earnings-tagged events, despite often positive fundamentals.

https://www.stocktitan.net/news/CI/the-cigna-group-s-first-quarter-2026-earnings-release-skvqsmlti6ij.html

Health Insurance Providers Stocks Q4 Recap: Benchmarking UnitedHealth (NYSE:UNH)

This article provides a Q4 recap for health insurance providers, benchmarking UnitedHealth (NYSE:UNH) against its peers. It details the financial performance, revenue beats and misses, and stock reactions for UnitedHealth, Clover Health (CLOV), Molina Healthcare (MOH), Centene (CNC), and Oscar Health (OSCR). The report highlights Clover Health as having the best Q4 performance relative to analyst estimates and Molina Healthcare as the weakest.

https://www.tradingview.com/news/stockstory:db2a9b752094b:0-health-insurance-providers-stocks-q4-recap-benchmarking-unitedhealth-nyse-unh/

Leerink sees UnitedHealth stock facing largest RADV audit exposure

Leerink's report indicates that the Centers for Medicare & Medicaid Services (CMS) is significantly expanding its 2020 Risk Adjustment Data Validation (RADV) audits, reviewing 470 Medicare Advantage contracts compared to 58 in 2018. UnitedHealth Group (NYSE:UNH) faces the most substantial exposure, with 60 contracts covering 92% of its 2020 Medicare Advantage membership under review. All publicly traded Medicare Advantage plans are included in these expanded audits, which will begin processing in April 2025.

https://www.investing.com/news/stock-market-news/leerink-sees-unitedhealth-stock-facing-largest-radv-audit-exposure-93CH-4592451

Rockland Trust Co. Purchases 63,538 Shares of Elevance Health, Inc. $ELV

Rockland Trust Co. significantly increased its stake in Elevance Health (NYSE:ELV) by 8,251.7%, purchasing 63,538 shares to bring its total holdings to 64,308 shares, valued at approximately $22.54 million. This move comes as Elevance Health reported Q4 EPS of $3.33, exceeding analyst expectations, and projected FY 2026 guidance at $25.50 EPS. The company maintains a "Moderate Buy" consensus rating from analysts with an average target price of $387.40, and also recently increased its quarterly dividend to $1.72 per share.

https://www.marketbeat.com/instant-alerts/filing-rockland-trust-co-purchases-63538-shares-of-elevance-health-inc-elv-2026-04-01/

Trending Today

Aave ($AAVE) Crypto Forecast: Down 5.4% Today

Sabre Corporation ($SABR) Stock Forecast: Up 6.0% Today

Tandem Diabetes Care, Inc. ($TNDM) Stock Forecast: Down 5.8% Today

Campbell Soup Company ($CPB) Stock Forecast: Down 5.1% Today

UnitedHealth Group Incorporated (DE) ($UNH) Stock Forecast: Up 9.2% Today

Patterson-UTI Energy Inc. ($PTEN) Stock Forecast: Up 5.1% Today

Palo Alto Networks Inc. ($PANW) Stock Forecast: Up 4.7% Today

Crowdstrike Holdings Inc. ($CRWD) Stock Forecast: Up 5.1% Today

Atlassian Corporation Plc ($TEAM) Stock Forecast: Down 5.1% Today

The Trade Desk Inc ($TTD) Stock Forecast: Down 6.3% Today

Centene Corporation Price History

01.03.2026 - CNC Stock was up 5.7%

• Centene Corporation (CNC) is a diversified healthcare company that provides programs and services to government-sponsored healthcare programs. Today, CNC experienced a strong bullish movement in the market.
• The bullish movement in CNC stock could be attributed to the positive sentiment in the healthcare sector following the strong performance of companies like UnitedHealth Group (UNH) and Elevance Health (ELV).
• The current market trend could be influenced by a recent analysis suggesting UnitedHealth Group might face a significant audit exposure, indirectly boosting CNC and emphasizing strength in the industry.
• Investor confidence in the healthcare sector, including CNC, may have been supported by a notable increase in stake in Elevance Health coupled with their positive Q4 earnings and FY 2026 guidance.
• The overall stability and growth potential of various healthcare companies, such as HCA Healthcare Inc., likely added to the positive market sentiment, further driving CNC's bullish movement.

11.02.2026 - CNC Stock was down 7.3%

• Reduction in stake by Capital World Investors in Molina Healthcare (MOH) may have signaled lack of confidence in the healthcare sector, impacting CNC's stock negatively.
• CNC's stock decline can be attributed to warnings of lower membership in Affordable Care Act plans and higher utilization patterns in specialty pharmacy, raising concerns about future revenue streams.
• The market's mixed performance with Centene lagging behind while BridgeBio Pharma led suggests a sector-specific issue affecting CNC rather than broader market conditions.
• Surge in Valero Energy and Baker Hughes stocks, driven by favorable oil prices, highlights a shift towards traditional energy sources, potentially diverting investor attention away from healthcare and renewable energy sectors like CNC and First Solar.

02.03.2026 - CNC Stock was up 5.2%

• CNC experienced a strong bullish movement today.
• The significant increase in stakes by HF Advisory Group LLC and Rockland Trust Co. in Elevance Health (ELV) could have positively impacted CNC's stock price, as ELV's strong financial performance and raised dividend likely boosted investor confidence in the healthcare sector.
• Leerink's report on UnitedHealth Group (UNH) facing substantial RADV audit exposure might have indirectly benefited CNC, as investors may have shifted their focus towards other healthcare companies with potentially lower audit risks.
• Overall, the positive sentiment surrounding healthcare stocks, driven by strong financial results and strategic investments, likely contributed to CNC's bullish market movement today.

20.02.2026 - CNC Stock was down 5.2%

• CNC experienced a strong bearish movement today.
• The decrease in CNC's stock price can be attributed to a lowered price target for the company from $45.00 to $41.00, along with a Neutral rating.
• This adjustment, combined with other revisions to price targets from various firms, has resulted in a varied sentiment among analysts regarding CNC's future performance.
• The overall negative trend in the healthcare sector, as illustrated by Molina Healthcare Inc. lagging behind its competitors, may have also adversely affected CNC's stock price today.

26.02.2026 - CNC Stock was up 5.1%

• CNC witnessed a notable uptick in its stock price today, potentially reflecting investor confidence in the company's operational resilience and diversification strategy in light of industry challenges.
• The recent 3.00% decline in CNC shares on March 25 appears to be a temporary market response, as financial analysts remain positive with an average target price of $45.71, suggesting considerable growth potential.
• The forthcoming April 25 earnings release is pivotal for CNC, with investors keenly observing how the company addresses rising Medicaid expenses and changes in its membership profile, seeking indications of financial stability and strategic direction in government healthcare.

10.01.2026 - CNC Stock was up 5.3%

• CNC stock surged due to the positive outlook provided in the company's 2025 results and 2026 guidance, with expectations of exceeding $3.00 in adjusted diluted EPS.
• The market responded favorably to Centene's efforts to restore its earnings power, despite reporting a GAAP diluted loss per share in 2025.
• The bearish movement in Humana stock hitting a 52-week low may have indirectly benefited CNC, as investors potentially shifted focus to Centene's growth potential within the healthcare sector.
• The overall positive sentiment towards CNC was reinforced by Morgan Stanley's "Hold" rating, with a price target of $38.00, indicating confidence in the company's future performance.

23.02.2026 - CNC Stock was down 5.1%

• CNC stock faced a bearish movement possibly due to analyst pressure amid healthcare sector headwinds and mixed forecasts, leading to a cautious "Hold" consensus.
• The increased scrutiny on Acadia Healthcare Co, a competitor in the behavioral health sector, due to a US Justice Department probe may have raised concerns about regulatory risks in the industry, impacting CNC's stock valuation.
• The comparison between UnitedHealth Group (UNH) and CNC, with UNH being highlighted for its consistent growth and profitability, might have also influenced investors to shift towards more stable options in the healthcare sector.
• The overall uncertainty in the healthcare industry, coupled with Centene's specific challenges such as Medicaid reimbursement issues and rising medical costs, could have contributed to the bearish movement in CNC stock today.

23.02.2026 - CNC Stock was down 5.0%

• Challenges in Medicaid reimbursement and rising medical costs are putting pressure on Centene Corp., resulting in a cautious sentiment and a consensus to "Hold."
• The decline in CNC's stock could be influenced by mixed performance indicators, including bearish trends in MACD, Bollinger Bands, and KST.
• The scrutiny faced by companies like Acadia Healthcare Co and HCA Healthcare Inc, within the healthcare sector due to regulatory issues and operational uncertainties, may have contributed to the negative sentiment surrounding CNC.
• The prevailing headwinds in the healthcare sector and uncertainties in the US healthcare landscape could have played a role in the drop in Centene Corp.’s stock value today.

12.02.2026 - CNC Stock was down 5.2%

• A price target cut on Centene Corp. following its fourth-quarter results and concerns about future challenges likely contributed to the bearish movement.
• The overall U.S. HMO industry, including Centene, is facing challenges such as escalating medical costs and regulatory hurdles, despite leveraging technology and M&A for expansion.
• Reducing its stake in UnitedHealth Group may have impacted market sentiment towards health insurance companies like Centene.
• Despite the industry's challenges, Centene and other key HMO companies are positioned for long-term growth, as highlighted by Zacks Equity Research, which could provide some optimism for investors amidst the bearish market movement.

24.02.2026 - CNC Stock was down 5.6%

• The bearish movement in CNC's stock could be influenced by the overall mixed market sentiment towards healthcare companies and regulatory pressures.
• The positive earnings report from Jabil Inc. and the subsequent sector-wide rally might have shifted investor focus away from CNC, impacting its stock performance negatively.
• CNC might also be facing specific challenges or concerns within the healthcare sector, leading to a reevaluation of its prospects by investors.
• While CNC's performance today was bearish, it could present a potential buying opportunity for investors looking to capitalize on any short-term market fluctuations in the healthcare industry.

10.02.2026 - CNC Stock was down 12.3%

• Today, Centene Corporation (CNC) experienced a strong bearish movement in the market, likely influenced by several factors:
• CNC's participation in the Barclays Global Healthcare Conference may have led to profit-taking by investors, as the reaffirmed guidance may not have met heightened expectations.
• The partial redemption of $1 billion of its notes could have raised concerns about the company's financial position and future growth prospects, leading to a sell-off.
• The overall negative sentiment towards healthcare stocks, as evidenced by the performance of other healthcare companies like Elevance Health, could have also contributed to CNC's bearish movement.
• The reduction in stake by the Swiss National Bank in Elevance Health, a healthcare company, might have signaled broader concerns about the sector, impacting CNC's stock price negatively.

10.02.2026 - CNC Stock was down 8.9%

• Today's bearish movement in CNC stock can be attributed to a combination of factors:
• Concerns over regulatory issues with CMS regarding Medicare Advantage drug plans and an expected decline in Medicare Advantage members affecting future performance.
• A reduction in stake by institutional investors like the Swiss National Bank and Vinva Investment Management Ltd signaling uncertainties in Elevance Health's prospects, impacting CNC due to its association with the healthcare industry.
• Market reacting to the overall uncertainty in the healthcare sector and broader market sentiment, despite Centene Corporation reaffirming its 2026 financial guidance at the conference.
• Analysts' positive long-term outlook on Elevance Health's recovery and Centene's financial performance potentially offering support, though short-term concerns and market dynamics influencing CNC's bearish trend.